Back to News
Market Impact: 0.28

Journey Medical Corporation (DERM) Reports Q1 Loss, Beats Revenue Estimates

DERM
Corporate EarningsCompany FundamentalsAnalyst EstimatesHealthcare & Biotech

Journey Medical reported quarterly EPS of -$0.08, missing the Zacks consensus estimate of -$0.07 by $0.01 per share. The loss narrowed from -$0.18 per share a year ago, indicating year-over-year improvement despite a slight earnings miss.

Analysis

Journey Medical reported quarterly EPS of -$0.08, missing the Zacks consensus estimate of -$0.07 by $0.01 per share. The loss narrowed from -$0.18 per share a year ago, indicating year-over-year improvement despite a slight earnings miss.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

mildly negative

Sentiment Score

-0.18

Ticker Sentiment

DERM-0.15